In our studies, we suggested that m6A modification of PLK1 mRNA could be recognized by m6A “reader” YTHDF1, which then induced PLK1 translational rate in prostate cancer, thus promoting prostate cancer progression. Here, PLK1 is linked to prostate carcinoma.